What does OPHTASENS do?

OPHTASENS is a specialist medical practice in Sint-Gillis (bij-Brussel). Private Limited, started on 2 December 2021, 1 establishment.

What is the address of OPHTASENS?

The registered office of OPHTASENS is located at Defacqzstraat 134, 1060 Sint-Gillis (bij-Brussel).

Is OPHTASENS still active?

Yes. According to the CBE (18 September 2026) OPHTASENS is active, legal situation “Normale toestand”, started on 2 December 2021.

Is OPHTASENS registered on Peppol?

Yes, OPHTASENS is registered on the Peppol network with ID 0208:0777945245.

What is the enterprise number of OPHTASENS?

The enterprise number of OPHTASENS is BE0777945245.

When was OPHTASENS founded?

OPHTASENS was founded on 2 December 2021.

Who are the directors of OPHTASENS?

According to the 2025 annual accounts, the directors of OPHTASENS are: LISA SCIFO.

Is OPHTASENS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 December 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did OPHTASENS make in 2025?

OPHTASENS posted a profit after taxes of € 54,853 in financial year 2025.

What is the revenue of OPHTASENS?

As a small company, OPHTASENS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 82,831.

OPHTASENS (Private Limited) - Sint-Gillis (bij-Brussel)

Dossier OPHTASENS, printed on 18 September 2026 from databakkes.be/en/0777945245/ophtasens. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

OPHTASENS from Sint-Gillis (bij-Brussel), company number BE0777945245, closed financial year 2025 with a result of € 54,853 after tax. For that financial year OPHTASENS recorded a gross margin of € 82,831 and equity of € 209,648. Compared with financial year 2024, the result moved from € 93,860 to € 54,853. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 17, 2026.

What it is worth Healthy

€ 209,648

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 54,853

▼ 42% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 254,561

▲ 49% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 54,853 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost estimate Staff cost at a one-person company Staff Only people on the payroll count here.€ 1,520 Likely the director’s social contribution or pension premium.The director’s pay Already netted into the gross margin, not shown separately in the accounts. Typical for one-person companies € 45,000 gross per year minimum for the reduced tax rate≈ € 2,100 net per month after contributions, tax and usually some benefits in kind, roughly Assumption based on the chart of accounts, not a figure from the source.

€ 1,520

▲ 73% vs 2024

No payroll staff. An amount this small is usually a social contribution or pension premium for the director, booked under staff costs.

Vehicles and equipment

€ 4,694

▲ 7% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,219

▼ 82% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 26,735

▲ 96% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 132,611 Gross margin 2022: € 132,611 First fiscal year in the series	€ 27,671 Gross margin 2023: € 27,671 ▼ 79% vs 2022 (€ 132,611) Unfavourable step	€ 137,386 Gross margin 2024: € 137,386 ▲ € 109,715 vs 2023 (€ 27,671) Favourable step	€ 82,831 Gross margin 2025: € 82,831 ▼ 40% vs 2024 (€ 137,386) Unfavourable step	▼ 40%
Profit after taxes	€ 93,997 Profit after taxes 2022: € 93,997 First fiscal year in the series	€ 16,791 Profit after taxes 2023: € 16,791 ▼ 82% vs 2022 (€ 93,997) Unfavourable step	€ 93,860 Profit after taxes 2024: € 93,860 ▲ € 77,069 vs 2023 (€ 16,791) Favourable step	€ 54,853 Profit after taxes 2025: € 54,853 ▼ 42% vs 2024 (€ 93,860) Unfavourable step	▼ 42%
Equity	€ 98,997 Equity 2022: € 98,997 First fiscal year in the series	€ 115,788 Equity 2023: € 115,788 ▲ 17% vs 2022 (€ 98,997) Favourable step	€ 209,648 Equity 2024: € 209,648 ▲ 81% vs 2023 (€ 115,788) Favourable step	€ 209,648 Equity 2025: € 209,648 Unchanged (€ 209,648) Unchanged
Total debts	€ 44,245 Total debts 2022: € 44,245 First fiscal year in the series	€ 61,187 Total debts 2023: € 61,187 ▲ 38% vs 2022 (€ 44,245) Unfavourable step	€ 25,925 Total debts 2024: € 25,925 ▼ 58% vs 2023 (€ 61,187) Favourable step	€ 83,628 Total debts 2025: € 83,628 ▲ 223% vs 2024 (€ 25,925) Unfavourable step	▲ 223%
Cash	€ 92,161 Cash 2022: € 92,161 First fiscal year in the series	€ 146,652 Cash 2023: € 146,652 ▲ 59% vs 2022 (€ 92,161) Favourable step	€ 170,495 Cash 2024: € 170,495 ▲ 16% vs 2023 (€ 146,652) Favourable step	€ 254,561 Cash 2025: € 254,561 ▲ 49% vs 2024 (€ 170,495) Favourable step	▲ 49%
Retained profit	€ 93,997 Retained profit 2022: € 93,997 First fiscal year in the series	€ 110,788 Retained profit 2023: € 110,788 ▲ 18% vs 2022 (€ 93,997) Favourable step	€ 204,648 Retained profit 2024: € 204,648 ▲ 85% vs 2023 (€ 110,788) Favourable step	€ 204,648 Retained profit 2025: € 204,648 Unchanged (€ 204,648) Unchanged
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 54,853 Dividend 2025: € 54,853 Unchanged (€ 0) Unchanged
Balance sheet total	€ 143,242 Balance sheet total 2022: € 143,242 First fiscal year in the series	€ 176,976 Balance sheet total 2023: € 176,976 ▲ 24% vs 2022 (€ 143,242) Unchanged	€ 235,573 Balance sheet total 2024: € 235,573 ▲ 33% vs 2023 (€ 176,976) Unchanged	€ 293,275 Balance sheet total 2025: € 293,275 ▲ 24% vs 2024 (€ 235,573) Unchanged	▲ 24%

Key figures of OPHTASENS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to OPHTASENS?

What happened at OPHTASENS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 17, 2026 New annual accounts for financial year 2025: profit of € 54,853 (▼ 42% vs 2024). Source: NBB ↗
Dec 2, 2021 New establishment in Sint-Gillis (bij-Brussel). KBO
Dec 2, 2021 Start of the company according to the CBE. KBO

In short

From € 93,997 profit in 2022 to € 54,853 profit in 2025.

Paid € 102,163 in corporate taxes since 2022.

Best year ever: 2022, with € 93,997 profit.

Paid out € 54,853 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at OPHTASENS? We notify you, reason included.

Follow OPHTASENS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

LISA SCIFO

OPHTASENS

Behind OPHTASENS is LISA SCIFO.

See the full network in the app

Directors

According to the 2025 annual accounts

LISA SCIFO

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Defacqzstraat 134

1060 Sint-Gillis (bij-Brussel)

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Associations des copropriétaires à Saint-Gilles Rue Defacqz, 134

UROSENS

€ 174,377 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0777.945.245
VAT number: BE 0777.945.245
Registered office: Defacqzstraat 134, 1060 Sint-Gillis (bij-Brussel)
Names & denominations: OPHTASENS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 2 December 2021
Peppol: Active · Active since 15 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗